Open AccessEconomic evaluation plan of a RCT of hydroxyapatite-coated uncemented hemiarthroplasty versus cemented hemiarthroplasty for the treatment of displaced intracapsular hip fractures
Author(s) -
May Ee Png,
Miguel Fernandez,
Juul Achten,
Nicholas R. Parsons,
Alwin McGibbon,
Jenny Gould,
Xavier L Griffin,
Matthew L. Costa
Publication year - 2020
Publication title -
bone and joint open
Language(s) - English
Resource type - Journals
ISSN - 2633-1462
DOI - 10.1302/2633-1462.13.bjo-2020-0003
Subject(s) - medicine , randomized controlled trial , economic evaluation , physical therapy , hip fracture , surgery , osteoporosis , pathology , endocrinology
Aim This paper describes the methods applied to assess the cost-effectiveness of cemented versus uncemented hemiarthroplasty among hip fracture patients in the World Hip Trauma Evaluation Five (WHiTE5) trial.Methods A within-trial cost-utility analysis (CUA) will be conducted at four months postinjury from a health system (National Health Service and personal social services) perspective. Resource use pertaining to healthcare utilization (i.e. inpatient care, physiotherapy, social care, and home adaptations), and utility measures (quality-adjusted life years) will be collected at one and four months (primary outcome endpoint) postinjury; only treatment of complications will be captured at 12 months. Sensitivity analysis will be conducted to assess the robustness of the results.Conclusion The planned analysis strategy described here records our intent to conduct a within-trial CUA alongside the WHiTE5 trial.